The stock has gained in six out of the last eight trading sessions, during which it has seen gains of 32%.
Hopes of parent company Tata Sons listing as a public company have yet again stoked value unlocking hopes for Tata Chemicals and its shareholders. As per its 2025 annual report, Tata Chemicals held 10,237 securities in Tata Sons, worth ₹57 crore.
In a statement released last week, Shapoorji Pallonji Mistry said that the timely listing of Tata Sons is a necessary evolution, and fundamentally in public interest.
The statement further said that the listing of Tata Sons will reinforced corporate governance, and deepen transparency and accountability.
“We look towards the RBI for a decisive direction with regards to the listing,” the statement added.
Under the current rules, Tata Sons is classified as an upper-layer NBFC, which mandates it to list by September 30,2025. Tata Sons is in fact, the only one among the 15 upper-layer NBFCs that are yet to comply with this directive.
The company had cleared debt worth ₹22,000 crore by March 2024 to seek exemption from this classification.
As per the latest draft amendment directions, the RBI has proposed to scrap parametric scoring model for upper-layer NBFC classifications. NBFCs worth ₹1 lakh crore in assets will be called an upper-layer NBFC under the proposed rules.
The central bank has also proposed the removal of restricting government NBFCs entering the upper-layer category.
In an interaction with CNBC-TV18, Abizer Diwanji, the founder of NeoStrat Advisors LLP said that the Tata Sons is not affected either way by the RBI draft norms, but the issues whether it should be classified as an NBFC to begin with.
He added that the only for Tata Sons to get out of this list is to declassify themselves as an NBFCs because if it is still considered one, it must list.
Shares of Tata Chemicals are off opening highs, currently trading 7.2% higher at ₹740.
